Both Shed and Luma Health are legitimate compounded GLP-1 platforms. The core difference is pricing structure and transparency: Shed's pricing varies by format and increases with dose escalation (roughly $200–$299/month at maintenance for injections), while Luma Health charges a single flat rate at every dose from 0.25 mg to 2.4 mg.
Shed — Better If...
You want format flexibility (injections, drops, or lozenges), a competitive starting price for the first month or two, or a contractual weight-loss refund guarantee — and are comfortable with dose-tier pricing increases as you escalate toward maintenance.
Luma Health — Better If...
You want flat-rate pricing at every dose tier ($197/month sema, $297/month tirz), maximum pharmacy transparency (VialsRX, TX #35264), tirzepatide as a core offering, and no contracts.
What Is Shed (Shed Rx)?
Shed — sometimes referred to as Shed Rx — is a direct-to-consumer GLP-1 telehealth platform based in Arizona, operating since 2022. Shed offers one of the broadest medication menus in the space: compounded semaglutide and tirzepatide available as weekly injections, daily sublingual drops, or dissolvable lozenges, alongside brand-name Wegovy and Zepbound and an FDA-approved oral GLP-1 option. Like Luma Health, Shed operates in the cash-pay market: patients complete an online health intake, a licensed provider issues a prescription, and medication is shipped directly to the patient's door. No insurance is required.
Shed has built a consumer presence in the GLP-1 market through social media marketing, a competitive entry-level price point, and a publicized weight-loss money-back guarantee. The platform is legitimate — it operates with licensed US providers and sources compounded medications from licensed 503A pharmacies. The primary questions for patients comparing Shed to Luma Health are: what is the all-in monthly cost at the maintenance dose where most patients spend most of their treatment time, how transparent is the pharmacy relationship, and what happens to pricing as doses increase.
The Pricing Structure: Where Shed and Luma Health Diverge
The most important pricing comparison between Shed and Luma Health is not the starting dose price — it is the maintenance dose price, because that is where patients spend the majority of their GLP-1 treatment course.
Semaglutide titration typically follows a schedule of 0.25 mg/week for weeks 1–4, 0.5 mg for weeks 5–8, 1.0 mg for weeks 9–12, and then 1.7 mg and 2.4 mg (the therapeutic Wegovy dose) thereafter. Most patients will reach maintenance doses within 3 to 5 months and remain there for the duration of their treatment. The price at that maintenance dose — not the starting dose — is the economically relevant comparison.
Shed — Compounded Sema (Injection)
★ Luma Health — Compounded Sema
Shed's Genuine Strengths
💉 Format Flexibility
Shed offers compounded semaglutide and tirzepatide as weekly injections, daily sublingual drops, or dissolvable lozenges — a genuine advantage for needle-averse patients that most competitors don't match. This flexibility is one of Shed's clearest differentiators in the market.
💰 Competitive Entry Pricing
Shed's starting-dose price is lower than Luma Health's $197/month flat for the first 1 to 2 months of treatment. For patients on a tight budget who are uncertain about GLP-1 and want to test it at the lowest possible initial cost before committing to a longer treatment course, Shed's entry price is a genuine advantage at that specific window.
🏆 Weight-Loss Guarantee
Shed publicizes a money-back guarantee tied to a body-weight loss threshold for eligible new patients — a contractual commitment that few competitors offer in writing. For risk-averse patients, this is worth reviewing in the terms before enrolling.
📱 App Experience
Shed has invested in its digital patient experience including a mobile-friendly platform and messaging capabilities. The quality of the patient-facing platform experience can matter for patients who want a polished consumer product feel from their GLP-1 provider rather than a purely clinical interaction.
Full Feature Comparison
| Factor | Shed (Shed Rx) | Luma Health |
|---|---|---|
| Sema starting price | ~$129–$199/mo | $197/mo flat |
| Sema maintenance price | ~$200–$299/mo (dose-dependent) | $197/mo flat — same always |
| Dose-tier increases | Yes — price rises as you escalate | ✓ None — flat at all doses |
| Tirzepatide | Available — verify current pricing | ✓ $297/mo flat — core offering |
| Medication formats | ✓ Injection, drops, lozenges, brand pill | Injection (vial + syringe) |
| Pharmacy named publicly | Not prominently disclosed | ✓ VialsRX, TX Board #35264, verifiable at pharmacy.texas.gov |
| Clinical provider named | Licensed provider network | ✓ Wasef Health, PC |
| Consultations included | Varies by plan | ✓ $0 — always included |
| Shipping | May be additional | ✓ $0 — free, all 50 states |
| Contract required | Some plans require commitment | ✓ None — cancel anytime |
| 12-mo sema (maintenance) | ~$2,400–$3,588 | $2,364 (flat) |
| Pricing predictability | Variable — plan, format, and dose dependent | ✓ Fixed — same every month |
The Pharmacy Transparency Question
One meaningful operational difference between Shed and Luma Health is the specificity of pharmacy disclosure. When you enroll with Luma Health, the compounding pharmacy is publicly named — VialsRX, licensed by the Texas State Board of Pharmacy (license #35264), verifiable independently at pharmacy.texas.gov. You can look up that license before providing any payment information and confirm that the pharmacy is active, licensed, and in good standing with the state regulator.
Shed's pharmacy disclosure is less specific in public marketing. Patients who ask Shed directly should be able to receive information about which pharmacy fills their prescription, but the information is not as prominently surfaced as Luma Health's publicly disclosed VialsRX partnership. For injectable compounded medications — where sterility, potency accuracy, and regulatory compliance are safety-critical — independent pharmacy verification is a reasonable due diligence step that Luma Health makes easier.
This is not a claim that Shed uses substandard pharmacies. It is an observation that pharmacy transparency varies between providers and that Luma Health's proactive disclosure provides a verification pathway that Shed's public materials do not currently offer equivalently.
Who Each Platform Is Right For
Consider Shed If...
- You want format flexibility — injections, drops, or lozenges — and needle aversion is a real barrier for you
- You want the lowest possible starting price for the first 1 to 2 months of treatment and will reassess after that window
- A contractual weight-loss money-back guarantee matters to your decision
- You are comfortable with dose-tier pricing that will increase as you escalate toward maintenance doses
★ Choose Luma Health If...
- You are planning a 6+ month GLP-1 treatment course and want the same all-in price at your starting dose and your maintenance dose
- You want maximum pharmacy transparency — a named, publicly verifiable pharmacy license you can confirm before paying
- Tirzepatide is important to you now or may become important — Luma Health offers it as a core offering at $297/month flat
- You want no contracts and month-to-month flexibility without multi-month commitment obligations
How to Switch from Shed to Luma Health
Start Luma Health's intake before stopping Shed
Complete the health intake at start.mylumahealth.com while you still have 2 to 3 weeks of Shed medication remaining. Provider review and shipping together take 7 to 12 days — starting before your supply runs out prevents any treatment gap.
Document your current dose clearly
During the intake, specify your current semaglutide dose (e.g., 1.0 mg/week), how long you have been at that dose, and any side effects. Your Wasef Health, PC provider will prescribe at your current dose — no titration restart required.
Wait for VialsRX shipping confirmation
After prescription approval (24 to 48 hours), VialsRX prepares and ships your medication within 5 to 10 business days. Do not cancel Shed until you have a shipping confirmation from Luma Health and a realistic delivery date.
Cancel Shed and confirm in writing
Cancel your Shed subscription through their account portal or customer support. Get written confirmation of the cancellation. Check that no additional charge processes after your cancellation date — particularly if you are on a plan with any prepaid component.
Continue at your current dose on your injection schedule
When your Luma Health medication arrives, inject at your next scheduled weekly dose. No washout, no restart. The active ingredient (semaglutide) is the same regardless of which platform filled the prescription.
No dose-tier increases.
$197/mo flat, always.
Compounded semaglutide $197/month flat. VialsRX pharmacy (TX Board #35264). No contracts. Wasef Health, PC clinical oversight.
Start With Luma Health →Frequently Asked Questions
At starting doses, Shed's entry price (~$129–$199/month) can be lower than Luma Health's $197/month flat. At maintenance doses — where patients spend most of their treatment time — Shed's injection pricing reaches $200 to $299/month depending on dose tier, while Luma Health remains $197/month flat. Over a 12-month treatment course, the annual cost at Shed's maintenance-dose range ($2,400–$3,588) is comparable to or higher than Luma Health's $2,364 flat total. The most accurate comparison is the all-in cost at your specific maintenance dose, not the starting price.
Shed offers compounded tirzepatide, though current pricing and availability should be verified directly at shed.health before enrolling, as medication offerings in the compounded GLP-1 market can change based on regulatory conditions and pharmacy capacity. Luma Health offers compounded tirzepatide at $297/month flat as a core offering consistently available in all 50 states.
Shed's compounding pharmacy is not prominently disclosed in public marketing materials. Patients who want this information should ask Shed directly before enrolling and request the pharmacy's name and state board license number for independent verification. For injectable compounded medications, knowing which pharmacy prepares your medication and being able to verify their license status independently is a basic quality assurance step. Luma Health uses VialsRX (Texas State Board of Pharmacy license #35264), verifiable at pharmacy.texas.gov without needing to contact customer support.
Yes. Switching from Shed to Luma Health does not require restarting titration — you continue at your current dose. The active pharmaceutical ingredient (semaglutide) is the same regardless of which licensed compounding pharmacy prepared it. Your Luma Health provider will prescribe at your current dose level based on your documented treatment history. The practical steps are: complete the Luma Health intake while you still have Shed medication, wait for your VialsRX shipment to confirm, then cancel Shed and continue injecting on your regular schedule.
Yes. Both Shed and Luma Health are legitimate telehealth platforms delivering real compounded semaglutide through licensed US healthcare providers and licensed compounding pharmacies. The differences are in pricing structure, pharmacy transparency, tirzepatide availability, and contract flexibility — not in legitimacy or the fundamental clinical approach.
Shed's pricing generally increases as patients escalate from starting doses to maintenance doses. The starting price of approximately $129 to $199/month applies to lower dose tiers; maintenance doses can reach $200 to $299/month. This means the monthly bill you receive may be higher at months 3, 4, and 5+ of treatment than at months 1 to 2. Luma Health's $197/month flat rate applies at every dose tier from 0.25 mg to 2.4 mg — the number you see when you enroll is the number you pay at every maintenance dose throughout your treatment.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed 33755728
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- Novo Nordisk. Wegovy (semaglutide) Prescribing Information. FDA.gov — Wegovy PI
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A vs 503B. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- Shed Weight Loss. Official Website. shed.health